Oaktree Acquisition Corp. III Life Sciences Warrant (OACCW) is a special purpose acquisition company (SPAC) aimed at capitalizing on high-growth opportunities in the life sciences sector. Backed by the esteemed Oaktree Capital Management, the firm leverages its extensive expertise and vast resources to identify and accelerate innovation in healthcare. This warrant offers institutional investors a strategic avenue to engage with the dynamic life sciences market, bolstered by Oaktree's extensive network and deep industry insights, positioning it as a compelling investment opportunity in a rapidly evolving landscape.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -0.38% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.29 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | -16.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $18.46M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Volatility is currently contracting